Sector-specific news and analysis
30 articles
Analysts are increasingly bullish on silver's prospects, suggesting it could outperform gold due to strong industrial demand and favorable valuation dynamics, despite both precious metals currently consolidating.
As India aggressively pursues its renewable energy goals, the demand for robust Battery Energy Storage Systems (BESS) is set to surge, creating potential opportunities for select Indian stocks.
Projections indicate private sector banks could experience a more significant rise in Non-Performing Assets (NPAs) by FY27 compared to their public sector counterparts, primarily driven by increased exposure to unsecured loans.
India's housing finance sector offers a compelling macro story, acting as a significant economic multiplier despite historical volatilities. Experts indicate potential upside in select stocks.
With India bracing for severe heatwaves, anticipation of surging electricity demand has driven significant interest and upward movement in power sector stocks like Tata Power and Adani Power.
Explore the key factors influencing Tata Steel's share price, from global commodity trends to domestic demand, offering insights into its market performance and historical movements.
Escalating geopolitical tensions in West Asia are driving increased military spending, creating significant growth opportunities for India's defence sector. Here are five stocks worth monitoring.
JLL warns that Indian construction projects face significant cost pressures in 2026 as labour rates and material prices continue climbing, despite strong housing demand fundamentals.
The geopolitical tensions in the Gulf region have exposed India's vulnerability to LNG supply disruptions. Understanding the supply chain architecture and its impact on different sectors is crucial for investors navigating market volatility.
India's GLP-1 medication market is poised for explosive growth, with the market expected to reach ₹12,000 crore within five years as generic semaglutide launches drive accessibility and competition among pharmaceutical companies.